Phase II Trial of Sorafenib in Combination with Capecitabine in Patients with Hepatocellular Carcinoma: INST 08‐20

por Patt, Yehuda, Rojas‐Hernandez, Cristhiam, Fekrazad, Houman Mohammad, Bansal, Pranshu, Lee, Fa Chyi
Publicado 2017